CE, A., T, G., JP, B., J, B., SP, C., M, K., . . . AA, V. (2026). Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE. JACC. Heart failure, 102999. https://doi.org/10.1016/j.jchf.2026.102999
Chicago Style (17th ed.) CitationCE, Angermann, et al. "Empagliflozin in De Novo Vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE." JACC. Heart Failure 2026: 102999. https://doi.org/10.1016/j.jchf.2026.102999.
MLA (9th ed.) CitationCE, Angermann, et al. "Empagliflozin in De Novo Vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE." JACC. Heart Failure, 2026, p. 102999, https://doi.org/10.1016/j.jchf.2026.102999.
Warning: These citations may not always be 100% accurate.